Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Marissa A Boeck, MD, MPH
Headshot of Marissa A Boeck
Marissa A Boeck

Description

Summary

The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is:

• Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors?

Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.

Official Title

Identifying & Addressing Unmet Needs of Injury Survivors at a Safety Net Hospital in San Francisco

Keywords

Injury Traumatic, Survivorship, Trauma Injury, Social determinants of health, Community-engaged research, Unmet needs, Wounds and Injuries, Human-Centered Injury Thrivorship Pathway, Injury Thrivorship Pathway

Eligibility

You can join if…

Open to people ages 18 years and up

  • Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
  • Admitted to the hospital ≥ 24 hours
  • Discharged from the hospital alive
  • San Francisco resident or unhoused in San Francisco
  • Capacity for informed consent

You CAN'T join if...

  • Patient < 18 years old
  • Deceased during index hospitalization
  • Unable to provide informed consent

Location

  • Zuckerberg San Francisco General Hospital
    San Francisco California 94110 United States

Lead Scientist at UCSF

  • Marissa A Boeck, MD, MPH
    Marissa A. Boeck, M.D., M.P.H. is an Assistant Professor in the Department of Surgery, and serves as an acute care surgeon at Parnassus and as an acute care and trauma surgeon and surgical critical care intensivist at Zuckerberg San Francisco General Hospital (ZSFG).

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06292039
Study Type
Interventional
Participants
Expecting 25 study participants
Last Updated